Scientific advances helping to increase the number of available organs for transplantation
Dr. Ciara Shaver and other VUMC researchers were recently contributed to a Lancet article that suggested there are several new approaches that have been proven to increase the number of available organs for transplantation, including emerging techniques of rehabilitating organs that would have once been discarded as unusable.
Study: Heart failure patient questionnaire predicts hospitalization and mortality
According to a study recently published in the Journal of the American College of Cardiology, a patient-reported outcome measure (PROM) for adults with heart failure reliably predicted hospitalizations and mortality and outperformed all other electronic health record variables.
Medicine faculty receive Komen leadership grants
Susan G. Komen has awarded $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing breast cancer. The grant recipients include Department of Medicine faculty Drs. Tuya Pal (Genetic Medicine and Clinical Pharmacology) and Ben Ho Park (Hematology and Oncology).
Bequest from Wolfe family establishes endowed endocrinology fellowship
A lifelong passion for training and mentoring generations of endocrinologists has culminated in an endowment to support a new endocrinology fellowship in the Department of Medicine’s Division of Diabetes, Endocrinology and Metabolism. This is the result of an estate gift from the late Lawrence (Larry) Wolfe, MD, a Vanderbilt University School of Medicine alumnus and former faculty member, and his wife, Sarah (Sally) Wolfe.
VUMC-led research a step closer to understanding, preventing asthma
The findings, authored by Department of Medicine Drs. Tina Hartert, Dawn Newcomb and colleagues, suggest a possible way to identify susceptibility to - and prevent the development of - asthma and other severe respiratory problems later in life.
Study: Low blood cell counts drive cancer in explosive blood disorder
An analysis of genetic sequencing data from more than 34,000 people over a 17-year period by researchers at VUMC, including by Alex Bick, MD, PhD (Genetic Medicine), has found that persistent cytopenia appears to be a critical step in the progression of CHIP to blood cancer.